Screener
Boston Scientific BSX Research and development expense
Research and development expense at other companies
Other financials
Where this comes from
Reported directly by Boston Scientific in its filing.
Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.
The source filing: Boston Scientific’s 8-K, filed July 29, 2026. Open the filing →
- Filed
- Jul 29, 2026, 6:33 AM EDT
- Accession
- 0000885725-26-000051
FAQ
- What is Boston Scientific's research and development expense?
- Boston Scientific (BSX) reported research and development expense of $554M in Q2 2026.
- How has Boston Scientific's research and development expense changed year-over-year?
- Boston Scientific's research and development expense increased by 5.3% year-over-year, from $526M to $554M.
- What is the long-term trend for Boston Scientific's research and development expense?
- Over 4 years (2021 to 2025), Boston Scientific's research and development expense has grown at a 14.3% compound annual growth rate (CAGR), from $1.2B to $2.05B.
- What does research and development expense mean?
- Includes all costs incurred in the discovery and development of new products, technologies, or processes. For medical device companies, this is a critical investment area that drives future innovation and long-term competitive advantage.
Ask your AI about Boston Scientific's research and development expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude